CTKB Q2 2022 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+32.1% YoY

Gross Profit

$25M61.2% margin

Operating Income

-$891,000-2.2% margin

Net Income

-$598,000-1.5% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+14.5%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$493M

Total Liabilities

$82M

Stockholders' Equity

$411M

Cash & Equivalents

$350M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$30M	+32.1%
Gross Profit	$25M	$20M	+24.4%
Operating Income	-$891,000	$4M	-123.4%
Net Income	-$598,000	$3M	-122.4%

Revenue Segments

Product

$37M92%

Service

$3M8%

Geographic Segments

UNITED STATES

$25M62%

EMEA

$9M22%

Asia Pacific

$6M15%

Other

$418,0001%